AR229931A1 - Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea - Google Patents

Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea

Info

Publication number
AR229931A1
AR229931A1 AR282016A AR28201680A AR229931A1 AR 229931 A1 AR229931 A1 AR 229931A1 AR 282016 A AR282016 A AR 282016A AR 28201680 A AR28201680 A AR 28201680A AR 229931 A1 AR229931 A1 AR 229931A1
Authority
AR
Argentina
Prior art keywords
procedure
purified human
human fibroblast
produce interferon
essentially purified
Prior art date
Application number
AR282016A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR229931A1 publication Critical patent/AR229931A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/565IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AR282016A 1979-07-31 1980-07-31 Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea AR229931A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6237179A 1979-07-31 1979-07-31
US13063580A 1980-03-14 1980-03-14

Publications (1)

Publication Number Publication Date
AR229931A1 true AR229931A1 (es) 1984-01-31

Family

ID=26742182

Family Applications (1)

Application Number Title Priority Date Filing Date
AR282016A AR229931A1 (es) 1979-07-31 1980-07-31 Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea

Country Status (33)

Country Link
US (1) US5015730A (da)
JP (1) JPH02138226A (da)
AR (1) AR229931A1 (da)
AT (1) AT372387B (da)
AU (1) AU536274B2 (da)
CA (1) CA1146468A (da)
CH (1) CH648331A5 (da)
DE (1) DE3028919A1 (da)
DK (1) DK159825C (da)
DO (1) DOP1980002948A (da)
ES (1) ES493849A0 (da)
FI (1) FI70721C (da)
FR (1) FR2462167B1 (da)
GB (1) GB2055384B (da)
HK (1) HK40384A (da)
HU (1) HU185382B (da)
IE (1) IE50075B1 (da)
IL (1) IL60697A (da)
IT (1) IT1132269B (da)
KE (1) KE3364A (da)
LU (1) LU82673A1 (da)
MC (1) MC1337A1 (da)
MY (1) MY8500274A (da)
NL (1) NL8004361A (da)
NO (1) NO151158C (da)
NZ (1) NZ194495A (da)
PH (2) PH17738A (da)
PT (1) PT71625B (da)
RO (1) RO81474B (da)
SE (1) SE466290B (da)
YU (1) YU193480A (da)
ZA (1) ZA803943B (da)
ZW (1) ZW17980A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT72786B (en) 1980-04-03 1983-01-10 Biogen Nv Process for producing dna sequences recombinant dna molecules and human fibroplast interferon-like polypeptides
GR81946B (da) * 1980-09-25 1984-12-12 Genentech Inc
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4894330A (en) * 1986-12-23 1990-01-16 Cetus Corporation Purification of recombinant beta-interferon incorporating RP-HPLC
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
RS57549B1 (sr) 2005-08-26 2018-10-31 Ares Trading Sa Proces za pripremu glikoziliranog interferona beta
CA2625978A1 (en) 2005-12-09 2007-06-14 Ares Trading S.A. Method for purifying fsh or a fsh mutant
JP2011500756A (ja) * 2007-10-22 2011-01-06 メルク セローノ ソシエテ アノニム Fc融合タンパク質を精製する方法
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Also Published As

Publication number Publication date
JPH02138226A (ja) 1990-05-28
US5015730A (en) 1991-05-14
DE3028919C2 (da) 1988-02-18
GB2055384B (en) 1983-08-10
NO151158C (no) 1985-02-20
PH17738A (en) 1984-11-23
AT372387B (de) 1983-09-26
RO81474A (ro) 1983-04-29
RO81474B (ro) 1983-04-30
FI802400A (fi) 1981-02-01
SE466290B (sv) 1992-01-27
FR2462167B1 (fr) 1985-07-05
MY8500274A (en) 1985-12-31
NO151158B (no) 1984-11-12
NZ194495A (en) 1984-07-31
DK159825C (da) 1991-04-29
GB2055384A (en) 1981-03-04
DK328880A (da) 1981-02-01
FI70721B (fi) 1986-06-26
ES8200560A1 (es) 1981-11-16
IE801589L (en) 1981-01-31
FI70721C (fi) 1986-10-06
LU82673A1 (fr) 1982-02-17
YU193480A (en) 1984-04-30
IT8023801A0 (it) 1980-07-30
ZW17980A1 (en) 1981-03-18
CA1146468A (en) 1983-05-17
PT71625A (en) 1980-08-01
CH648331A5 (de) 1985-03-15
HK40384A (en) 1984-05-18
ATA395080A (de) 1983-02-15
MC1337A1 (fr) 1981-04-21
FR2462167A1 (fr) 1981-02-13
DE3028919A1 (de) 1981-02-19
IT1132269B (it) 1986-07-02
DOP1980002948A (es) 1989-04-20
AU6091480A (en) 1981-02-05
KE3364A (en) 1984-02-03
ES493849A0 (es) 1981-11-16
IL60697A (en) 1984-04-30
IL60697A0 (en) 1980-09-16
DK159825B (da) 1990-12-10
ZA803943B (en) 1981-06-24
NO802297L (no) 1981-02-02
SE8005498L (sv) 1981-02-01
AU536274B2 (en) 1984-05-03
IE50075B1 (en) 1986-02-05
NL8004361A (nl) 1981-02-03
PT71625B (en) 1981-12-17
HU185382B (en) 1985-01-28
PH18479A (en) 1985-07-18

Similar Documents

Publication Publication Date Title
AR229931A1 (es) Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea
ES490697A0 (es) Un metodo de producir proteinas de interferon humano de for-ma le
NZ192991A (en) Preparation of purified protein hydrolysate
DK478786D0 (da) Cystein-forarmede muteiner af biologisk aktive humantumornekrosefaktorproteiner
MC1423A1 (fr) Production microbienne d'interferon de fibroplaste humain
IT1127253B (it) Proteine purificate e procedimento per la loro preparazione
DK282380A (da) Engangsble
ES491432A0 (es) Procedimiento para obtener agentes de tratamiento de fibras queratinicas
KR860005620A (ko) 소아용 트레이닝 팬츠 등과 같은 일회용 속팬츠
DK154045C (da) Engangsble
BR8003841A (pt) Quadro de comutacao encoberto
AR227021A1 (es) Procedimiento de preparacion de concentrados de complejo protrombinico altamente purificado
ES535509A0 (es) Procedimiento para purificar interferon de humano
IT1036478B (it) Procedimento ed impianto per la fabricazione di libri cuciti
SE7805026L (sv) Aminohartskomposition i formfibrer
BR8007022A (pt) Fralda descartavel
DK31386A (da) Behandling af proliferative hudsygdomme
ES543524A0 (es) Procedimiento para preparar benzoxazolil- y benzotiazolil- aminoacidos
MX14287A (es) Procedimiento para preparar acidos oxoftalazinil-aceticos heterociclicos
AR229097A1 (es) Imidas de acidos succinicos y procedimiento para prepararlas
MX5066E (es) Procedimiento mejorado para la elaboracion de piridina y 3-metilpiridina
MX5672E (es) Procedimiento para la preparacion de acidos 2-piridil y 2-pirimidil-aminobenzoicos
IT1098014B (it) Separazione di aminoacidi in antipodi ottici
AT361617B (de) Gewinnung und reinigung von humaninterferon
DK41585D0 (da) Udtrykkelse af human alfa-1-antitrypsin i gaer